Akers Biosciences Announces Q3 2015 Earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Akers Biosciences (AKER) Reports Q3 Loss of $0.45/Share
November 13, 2015 7:08 AM ESTAkers Biosciences (NASDAQ: AKER) reported Q3 EPS of ($0.45), versus ($0.23) reported last year. Revenue for the quarter came in at $169.5 thousand, versus $453.3 thousand reported last year.
For earnings history and earnings-related data on Akers Biosciences (AKER) click here.
... More